MedCap AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009160872
SEK
540.00
-11 (-2.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,806.70
1,587.40
1,111.30
916.30
817.40
757.10
709.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,806.70
1,587.40
1,111.30
916.30
817.40
757.10
709.00
Raw Material Cost
1,548.40
1,351.30
946.70
797.40
728.20
664.40
655.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
464.90
412.80
295.40
272.70
219.80
196.10
183.30
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
18.50
15.60
16.40
9.40
9.10
9.30
3.90
Selling and Distribution Expenses
-30.20
-30.50
-21.60
-9.70
-9.10
-22.50
-21.70
Other Expenses
-43.93
-38.34
-27.78
-26.20
-20.90
-17.42
-15.82
Total Expenditure (Excl Depreciation)
1,562.30
1,365.80
959.10
807.80
739.00
673.10
663.00
Operating Profit (PBDIT) excl Other Income
244.4
221.6
152.20000000000002
108.5
78.4
84
46
Other Income
14.60
15.50
22.10
0.90
12.30
-2.50
0.40
Operating Profit (PBDIT)
360.50
326.60
243.20
174.50
147.90
129.60
72.30
Interest
18.50
15.60
16.40
9.40
9.10
9.30
3.90
Exceptional Items
21.10
0.80
-5.90
17.00
-0.10
0.00
-2.30
Gross Profit (PBDT)
258.30
236.10
164.60
118.90
89.20
92.70
53.30
Depreciation
101.50
89.50
68.90
65.10
57.20
48.10
25.90
Profit Before Tax
261.60
222.30
152.00
117.00
81.50
72.20
40.20
Tax
52.40
49.80
34.00
18.90
17.00
14.50
13.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
207.30
172.20
117.60
96.50
62.60
55.20
24.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
207.30
172.20
117.60
96.50
62.60
55.20
24.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.90
0.30
0.40
1.60
1.90
2.50
2.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
209.20
172.50
118.00
98.10
64.50
57.70
26.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.4
0.4
0.4
0.4
0.4
0.4
0.4
Reserves
1,282.00
1,022.90
856.30
696.00
595.70
327.90
271.30
Earnings per share (EPS)
13.99
11.59
7.94
6.52
4.24
3.99
0.04
Diluted Earnings per share
13.99
11.59
7.94
6.52
4.24
3.99
0.04
Operating Profit Margin (Excl OI)
13.53%
13.96%
13.7%
11.84%
9.59%
11.09%
6.49%
Gross Profit Margin
20.1%
19.64%
19.88%
19.87%
16.97%
15.89%
9.32%
PAT Margin
11.47%
10.85%
10.58%
10.53%
7.66%
7.29%
3.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 13.82% vs 42.84% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 21.28% vs 46.19% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 11.19% vs 40.71% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 18.59% vs -4.88% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of MedCap AB With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
1,806.70
884.09
922.61
104.36%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,806.70
884.09
922.61
104.36%
Raw Material Cost
1,548.40
344.74
1,203.66
349.15%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
464.90
341.17
123.73
36.27%
Power Cost
0
0
0.00
Manufacturing Expenses
18.50
5.68
12.82
225.70%
Selling and Distribution Expenses
-30.20
213.57
-243.77
-114.14%
Other Expenses
-43.93
-17.05
-26.88
-157.65%
Total Expenditure (Excl Depreciation)
1,562.30
734.68
827.62
112.65%
Operating Profit (PBDIT) excl Other Income
244.40
149.41
94.99
63.58%
Other Income
14.60
14.64
-0.04
-0.27%
Operating Profit (PBDIT)
360.50
224.56
135.94
60.54%
Interest
18.50
5.68
12.82
225.70%
Exceptional Items
21.10
-0.28
21.38
7,635.71%
Gross Profit (PBDT)
258.30
539.35
-281.05
-52.11%
Depreciation
101.50
60.51
40.99
67.74%
Profit Before Tax
261.60
158.09
103.51
65.48%
Tax
52.40
26.45
25.95
98.11%
Provisions and contingencies
0
0
0.00
Profit After Tax
207.30
131.65
75.65
57.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
207.30
131.65
75.65
57.46%
Share in Profit of Associates
0
0
0.00
Minority Interest
1.90
0.00
1.90
Other related items
0.00
0.00
0.00
Consolidated Net Profit
209.20
131.65
77.55
58.91%
Equity Capital
0
0
0.00
Face Value
0.40
0.05
0.00
Reserves
1,282.00
4,828.64
-3,546.64
-73.45%
Earnings per share (EPS)
13.99
2.58
11.41
442.25%
Diluted Earnings per share
13.99
2.58
11.41
442.25%
Operating Profit Margin (Excl OI)
13.53%
16.90%
0.00
-3.37%
Gross Profit Margin
20.10%
24.73%
0.00
-4.63%
PAT Margin
11.47%
14.89%
0.00
-3.42%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 180.67 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 13.82% vs 42.84% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 20.92 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 21.28% vs 46.19% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 34.59 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 11.19% vs 40.71% in Dec 2023

Annual - Interest
Interest 1.85 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 18.59% vs -4.88% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.53%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023